Cynthia Besch-Williford Selected Research

Progesterone Congeners

1/2015	Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.
8/2011	Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
9/2010	Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.
9/2010	Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice.
10/2007	Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.
7/2006	Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cynthia Besch-Williford Research Topics

Disease

22	Neoplasms (Cancer) 02/2022 - 01/2002
17	Breast Neoplasms (Breast Cancer) 02/2022 - 01/2002
5	Neoplasm Metastasis (Metastasis) 01/2019 - 09/2010
3	Carcinogenesis 02/2016 - 09/2010
3	Breast Diseases (Breast Disease) 08/2012 - 10/2007
2	Triple Negative Breast Neoplasms 01/2019 - 01/2017
2	Lymphatic Metastasis 06/2013 - 09/2010
2	Prostatic Neoplasms (Prostate Cancer) 06/2013 - 02/2007
1	Hyperplasia 08/2011
1	Plague (Bubonic Plague) 03/2011
1	Ischemia 01/2011
1	Xeroderma Pigmentosum (Kaposi's Disease) 07/2009
1	Body Weight (Weight, Body) 10/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2002
1	Osteoporosis 01/2002

Drug/Important Bio-Agent (IBA)

15	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2006
13	Estrogens (Estrogen)FDA Link 01/2019 - 01/2002
11	Progestins (Progestagens)IBA 02/2016 - 07/2006
8	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 02/2016 - 10/2007
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2007
6	Hormones (Hormone)IBA 02/2022 - 10/2007
6	Progesterone CongenersIBA 01/2015 - 07/2006
5	2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA 01/2011 - 10/2007
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 07/2006
4	Pharmaceutical PreparationsIBA 01/2019 - 01/2011
3	Estrogen ReceptorsIBA 02/2022 - 03/2009
3	EnzymesIBA 02/2022 - 07/2014
3	LuteolinIBA 01/2017 - 01/2015
3	FlavonoidsIBA 01/2015 - 08/2011
3	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2015 - 08/2011
3	anthraceneIBA 01/2010 - 07/2006
2	Estrogen Receptor betaIBA 02/2022 - 10/2007
2	LigandsIBA 02/2022 - 07/2006
2	lissamine rhodamine B (sulforhodamine B)IBA 02/2022 - 07/2014
2	CholesterolIBA 02/2022 - 07/2014
2	FumaratesIBA 02/2022 - 07/2014
2	Ro 48-8071IBA 02/2022 - 07/2014
2	lanosterol synthaseIBA 02/2022 - 07/2014
2	eprenetapoptIBA 01/2019 - 01/2018
2	PhosphatidylserinesIBA 01/2019 - 01/2018
2	ApigeninIBA 08/2012 - 08/2011
2	9,10-Dimethyl-1,2-benzanthraceneIBA 08/2011 - 09/2010
2	Norgestrel (DL-Norgestrel)FDA LinkGeneric 09/2010 - 09/2010
2	Progesterone FDA LinkGeneric 09/2010 - 07/2006
2	Norethindrone (Norethisterone)FDA LinkGeneric 09/2010 - 09/2010
2	Angiogenesis InhibitorsIBA 10/2007 - 07/2006
1	liquiritigeninIBA 02/2022
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2019
1	Tumor Suppressor Protein p53IBA 01/2018
1	Aldehyde DehydrogenaseIBA 01/2015
1	ImmunosorbentsIBA 01/2015
1	Fluvastatin FDA Link 07/2014
1	Simvastatin (Zocor)FDA LinkGeneric 07/2014
1	BombesinIBA 06/2013
1	Bombesin Receptors (Bombesin Receptor)IBA 06/2013
1	Peptides (Polypeptides)IBA 06/2013
1	3- (5'- hydroxymethyl- 2'- furyl)- 1- benzylindazoleIBA 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 01/2013
1	RANK LigandIBA 08/2012
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 08/2011
1	ChemokinesIBA 03/2011
1	CytokinesIBA 03/2011
1	Chemokine ReceptorsIBA 03/2011
1	CXC ChemokinesIBA 03/2011
1	Therapeutic UsesIBA 01/2011
1	Monoclonal AntibodiesIBA 01/2011
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2011
1	Estradiol (Delestrogen)FDA LinkGeneric 09/2010
1	Biological ProductsIBA 09/2010
1	Megestrol Acetate (Borea)FDA LinkGeneric 09/2010
1	CurcuminIBA 01/2010
1	turmeric extractIBA 01/2010
1	Carboplatin (JM8)FDA LinkGeneric 07/2009
1	DNA (Deoxyribonucleic Acid)IBA 07/2009
1	Cysteine (L-Cysteine)FDA Link 03/2009
1	Angiogenic ProteinsIBA 03/2009
1	matrigelIBA 10/2007
1	Estrogen Receptor alphaIBA 10/2007
1	Caseins (Casein)FDA Link 02/2007
1	saw palmetto extractIBA 02/2007
1	Phytosterols (Plant Sterols)IBA 02/2007
1	Mifepristone (RU 486)FDA Link 07/2006
1	Hemoglobins (Hemoglobin)IBA 10/2005
1	Phytoestrogens (Phytoestrogen)IBA 01/2002
1	GenisteinIBA 01/2002

Therapy/Procedure

9	Therapeutics 02/2022 - 10/2007
5	Hormone Replacement Therapy (Therapy, Hormone Replacement) 02/2016 - 08/2011
2	Drug Therapy (Chemotherapy) 01/2019 - 07/2009
2	Aftercare (After-Treatment) 02/2016 - 01/2011
2	Contraception (Birth Control) 09/2010 - 10/2007
1	Injections 09/2010
1	Estrogen Replacement Therapy 10/2007
1	Chemoprevention 02/2007